Breast cancer cell lines were exposed for 72 hours to 1μM of beta-casomorphin, the opioid receptor agonist DAMGO, the ERK activator apelin, or beta-casomorphin / apelin in the presence of the ACE2-specific peptide inhibitor DX600. Here, ACE2 is linked to breast carcinoma.